Related references
Note: Only part of the references are listed.Immunotherapy for type 1 diabetes
Davide Frumento et al.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2017)
Serine biosynthesis and transport defects
Ayman W. El-Hattab
MOLECULAR GENETICS AND METABOLISM (2016)
Sulfatide Preserves Insulin Crystals Not by Being Integrated in the Lattice but by Stabilizing Their Surface
Karsten Buschard et al.
JOURNAL OF DIABETES RESEARCH (2016)
Maternal Early Pregnancy Serum Metabolites and Risk of Gestational Diabetes Mellitus
Daniel A. Enquobahrie et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2015)
Thinking bedside at the bench: the NOD mouse model of T1DM
James C. Reed et al.
NATURE REVIEWS ENDOCRINOLOGY (2015)
Reviewing the Effects of l-Leucine Supplementation in the Regulation of Food Intake, Energy Balance, and Glucose Homeostasis
Joao A. B. Pedroso et al.
NUTRIENTS (2015)
β cell ER stress and the implications for immunogenicity in type 1 diabetes
Meghan L. Marre et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2015)
High dietary protein intake, reducing or eliciting insulin resistance?
A. Rietman et al.
EUROPEAN JOURNAL OF CLINICAL NUTRITION (2014)
Role of ceramide in diabetes mellitus: evidence and mechanisms
Sehamuddin Galadari et al.
LIPIDS IN HEALTH AND DISEASE (2013)
NKT Cells Stimulated by Long Fatty Acyl Chain Sulfatides Significantly Reduces the Incidence of Type 1 Diabetes in Nonobese Diabetic Mice
Lakshmimathy Subramanian et al.
PLOS ONE (2012)
Roles of ceramide and sphingolipids in pancreatic β-cell function and dysfunction
Ebru Boslem et al.
ISLETS (2012)
The Sphingolipid Rheostat: A Potential Target for Improving Pancreatic Islet Survival and Function
Claire F. Jessup et al.
Endocrine Metabolic & Immune Disorders-Drug Targets (2012)
The twists and turns of sphingolipid pathway in glucose regulation
Gergana M. Deevska et al.
BIOCHIMIE (2011)
Oral L-serine supplementation reduces production of neurotoxic deoxysphingolipids in mice and humans with hereditary sensory autonomic neuropathy type 1
Kevin Garofalo et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Type 1 Diabetes: Etiology, Immunology, and Therapeutic Strategies
Tom L. Van Belle et al.
PHYSIOLOGICAL REVIEWS (2011)
Membrane lipidome of an epithelial cell line
Julio L. Sampaio et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Deoxysphingoid bases as plasma markers in Diabetes mellitus
Mariana Bertea et al.
LIPIDS IN HEALTH AND DISEASE (2010)
Global analysis of the yeast lipidome by quantitative shotgun mass spectrometry
Christer S. Ejsing et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Sphingolipids, insulin resistance, and metabolic disease:: New insights from in vivo manipulation of sphingolipid metabolism
William L. Holland et al.
ENDOCRINE REVIEWS (2008)
Roles of L-serine and sphingolipid synthesis in brain development and neuronal survival
Yoshio Hirabayashi et al.
PROGRESS IN LIPID RESEARCH (2008)
Gluten-free but also gluten-enriched (gluten+) diet prevent diabetes in NOD mice; the gluten enigma in type 1 diabetes
David P. Funda et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2008)
Resveratrol improves health and survival of mice on a high-calorie diet
Joseph A. Baur et al.
NATURE (2006)
C16:0 sulfatide inhibits insulin secretion in rat β-cells by reducing the sensitivity of KATP channels to ATP inhibition
Karsten Buschard et al.
DIABETES (2006)
Involvement of sulfatide in beta cells and type 1 and type 2 diabetes
K Buschard et al.
DIABETOLOGIA (2005)
Serine palmitoyltransferase, a key enzyme of sphingolipid metabolism
K Hanada
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2003)
Heterogeneity of Type I diabetes: analysis of monozygotic twins in Great Britain and the United States
MJ Redondo et al.
DIABETOLOGIA (2001)
Treatment with sulfatide or its precursor, galactosylceramide, prevents diabetes in NOD mice
K Buschard et al.
AUTOIMMUNITY (2001)
Share Paper
